APADAZ 325 mg/1
Benzhydrocodone and Acetaminophen · TABLET · Zevra Therapeutics, Inc.
APADAZ is a tablet containing benzhydrocodone and acetaminophen at 325 mg/1, taken oral. Manufactured by Zevra Therapeutics, Inc..
Key Facts
- Brand Name
- APADAZ
- Generic Name
- Benzhydrocodone and Acetaminophen
- NDC Code (Product)
70040-0145- Manufacturer
- Zevra Therapeutics, Inc.
- Strength
- 325 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule II (Controlled)
- Application #
- NDA208653
- Marketing Start
- 02/23/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is APADAZ used for?
APADAZ contains Benzhydrocodone and Acetaminophen. It is a tablet taken oral. Consult your doctor for specific uses.
Is APADAZ a controlled substance?
Yes, APADAZ is classified as CII under the DEA Controlled Substances Act.
What is the generic name for APADAZ?
The generic name for APADAZ is Benzhydrocodone and Acetaminophen. There are no other listed brand versions of Benzhydrocodone and Acetaminophen.
What is the NDC code for APADAZ 325 mg/1?
The NDC (National Drug Code) for APADAZ 325 mg/1 is 70040-0145, listed by Zevra Therapeutics, Inc..
Other APADAZ Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)